Research and analysis of medical polymer materials: the market size in 2021 will be 246.998 billion yuan

In a broad sense, medical polymer materials refer to all polymer materials used in medical activities; in a narrow sense, they refer to functional polymer materials that are used for medical purposes, applied to the human body, have special properties, and meet special medical requirements.

Medical polymer materials are composed of polymer compound matrix and additives. According to the properties of synthetic materials, synthetic medical polymer materials can be divided into degradable synthetic medical polymer materials and non-degradable synthetic medical polymer materials.

The market size of China's medical polymer materials industry is showing a trend of rapid growth. From 2017 to 2021, the market size of China's medical polymer materials industry will increase from 82.484 billion yuan to 246.998 billion yuan, with a compound annual growth rate of 31.55%.

In the past five years, under the influence of factors such as relevant technological innovation, policy support, and increased medical consumption, the market size of China's medical polymer materials industry will continue to grow rapidly at a compound annual growth rate of 31.55%. Especially since 2020, affected by the epidemic Influenced by the rapid growth of demand for polymer materials for medical consumables, the market for medical polymer materials continues to expand.

The reasons for the continuous growth of the market size of China's medical polymer materials industry are mainly based on the following three aspects: (1) Outstanding performance advantages: In physiological environments, medical polymer materials are in direct contact with human blood, body fluids and tissues and organs, showing good performance. Its biocompatibility, stability and safety can assist the rapid recovery of human tissue and organ functions; (2) Significant application advantages: medical polymer materials are mainly used in the fields of tissue engineering, artificial organs, and controlled drug release. Orthopedics, Traumatology, Plastic Surgery and many other departments have applications. It has high technical content and is closely related to patient rehabilitation. It is widely used in the field of biomedicine and has significant application value; (3) Growth in medical demand: my country's aging population and The number of chronic disease groups is showing an increasing trend year by year. The social medical and health needs of the two groups are urgent, thereby promoting the development of the medical device and pharmaceutical industries, and driving the growth of market demand for raw materials such as medical polymer materials.

The midstream players in the medical polymer materials industry are R&D and production companies of medical polymer materials. From the perspective of the market situation, China’s medical polymer material production enterprises are divided into two types: local enterprises and foreign-funded enterprises.

Typical representatives of local enterprises include Shandong Weigao, Kindly, Sanxin Medical, etc. Foreign-funded enterprises include Lubrizol, Nordic Chemicals, DuPont, etc. Benefiting from the encouragement and guidance of national policies, local medical polymer manufacturers have developed rapidly, accounting for more than 65% of the market, and foreign-funded enterprises accounted for about 35%.

From the perspective of application level, low-end medical polymer materials are gradually localized, while high-end medical polymer materials still rely on imports. Since the construction of polymer disciplines, personnel training and product production all take a long time, foreign-funded enterprises engaged in the research and development and production of medical polymers earlier than local enterprises, with sufficient human resources, high production technology and technical level. The production technology of high-end medical polymer materials with special properties such as wear resistance is higher than that of local enterprises.